Evidence map›Paper›PMID 18852279›Full record

ArticleAntimicrobial agents and chemotherapy2008

Lysine-enriched cecropin-mellitin antimicrobial peptides with enhanced selectivity.

Hiromi Sato, Jimmy B Feix

Open access · greenAbstract read
In one paragraph

Article in Antimicrobial agents and chemotherapy, 2008. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed
1.4field-weighted citation impact, top 23% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

21 citing papers in PubMed, 36 citations in OpenAlex.

  1. Chemical Synthesis of Medin via a Removable Aggregation-Suppressing Linker.Journal of peptide science : an official publication of the European Peptide Society · 2025
    Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

Hiromi SatoDepartment of Microbiology and Molecular Genetics and Center for Biopreparedness and Infectious Disease, Medical College of Wisconsin, Milwaukee, WI 53226, USA.
Jimmy B Feix
Medical College of Wisconsin · US

Funding

Spin-Labeled Peptide AntibioticsR01GM068829 · NIGMS · MEDICAL COLLEGE OF WISCONSIN · PI FEIX, JIMMY · 2004 to 2010
$1.6M
NIGMS NIH HHS GM068829NIGMS NIH HHS R01 GM068829
6 · The paper itself

Abstract

Lysine-enriched analogs of the cecropin-mellitin hybrid peptide, CA(1-7) M(2-9) (designated CM15), designed with optimized amphipathicity, retained antimicrobial activities similar to that of wild-type CM15 and had substantially reduced levels of hemolytic activity and cytotoxicity toward cultured macrophages, resulting in enhanced selectivity. These lysine-enriched analogs provide templates for improved CM15 peptide or peptidomimetic antibiotics.

Indexed as

Anti-Infective AgentsAntimicrobial Cationic PeptidesAnimalsGram-Negative BacteriaHemolysisHumansLysineMacrophagesMiceMicrobial Sensitivity TestsSpecies SpecificityStaphylococcusAnti-Infective AgentsAntimicrobial Cationic Peptidesantimicrobial hybrid peptide CM15Lysine

Identifiers

PMID18852279
PMCPMC2592880
OpenAlexW1993842357

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.